Skip to content

Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty

Randomized Controlled Clinical Trial for Closed Incision Negative Pressure Wound Therapy (NPWT) Devices in Total Knee Arthroplasty (TKA)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07770633
Enrollment
300
Registered
2026-08-18
Start date
2026-09-01
Completion date
2030-12-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Obesity, Chronic Kidney Diseases, Smoking, Wound Surgical

Keywords

Total Knee Arthroplasty, Total Knee Replacement

Brief summary

This study is a single-center, prospective, randomized, open-label clinical trial evaluating three commercially available closed-incision negative pressure wound therapy (ciNPWT) devices: NPseal, PICO, and Prevena, in adult patients undergoing primary total knee arthroplasty (TKA) who meet predefined high-risk criteria for wound complications. A total of approximately 300 participants will be enrolled and randomized in a 1:1:1 fashion to receive one of the three study dressings applied over the closed surgical incision at the end of the procedure. All participants will otherwise receive standard perioperative and postoperative care. The primary follow-up period will extend through 90 days after surgery. The primary objective is to compare the incidence of 90-day surgical site complications, including superficial infection, wound dehiscence, seroma, and hematoma, across the three dressing groups. Secondary objectives include evaluation of device usability, patient experience, and device-related issues (such as loss of seal, alarms, tubing or pump problems, fluid saturation, and premature dressing changes), as well as assessment of the interaction between skin closure method and device performance. Research-specific activities are limited to eligibility confirmation, informed consent, randomization, administration of a brief postoperative patient survey at approximately postoperative day 7 and/or dressing removal, provider assessment of the dressing at removal, and collection of clinical outcomes from the medical record. No additional blood draws, imaging, or invasive procedures are required for participation. This study is designed to address a gap in the literature by providing head-to-head comparative data on commonly used ciNPWT systems in a high-risk primary TKA population, with the goal of informing postoperative wound management strategies in clinical practice.

Interventions

DEVICENP Seal

Designed to maintain negative pressure without an external battery-powered pump or canister.

DEVICEPICO

Designed to deliver negative pressure for up to 7 days and has visual alerts for issues such as air leaks, low battery, or dressing change

DEVICEPrevena

Designed to deliver continuous negative pressure over the closed incision and collect fluid in a separate canister.

Sponsors

The Cleveland Clinic
Lead SponsorOTHER
Stryker Instruments
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * Undergoing primary total knee arthroplasty * Able to understand the study, provide informed consent, and participate in study procedures Meet at least one of the following co-morbidities: * BMI ≥35 * Diabetes * Prior surgical incision(s) in the operative area * Chronic kidney disease

Exclusion criteria

* Prisoners * Pregnant women * Patients who indicate they may not comply with post-operative instructions * Patients with active bleeding

Design outcomes

Primary

MeasureTime frameDescription
Surgical complicationsFrom day of surgery to 90days post-opIncidence of 90-day surgical site complications among patients receiving NPseal, PICO, or Prevena dressings.

Secondary

MeasureTime frameDescription
Device PerformanceFrom day of surgery to 90days post-opDevice usability using patient survey responses and provider assessments.
Closure TechniquesFrom day of surgery to 90days post-opShort-term clinical outcomes by skin closure technique.

Contacts

CONTACTNicolas Piuzzi, MD
piuzzin@ccf.org216-445-9109
CONTACTBrittany McKnight, BA
mcknigb@ccf.org440-262-0318

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026